Notice of annual general meeting The following information to be discussed at the forthcoming AGM is important and requires your immediate attention.
If you are in any doubt about the action you should take, you should seek advice from your stockbroker, bank manager, solicitor, accountant or other financial adviser authorised under the Financial Services and Markets Act 2000 as amended.
If you have sold or transferred all of your ordinary shares in the Company, you should pass this document, together with any other accompanying documents, at once to the purchaser or transferee, or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for onward transmission to the purchaser or transferee.
NOTICE OF ANNUAL GENERAL MEETING AGM Notice is hereby given that the third AGM of Woodford Patient Capital Trust plc the Company will be held at 10.30am on Thursday, 16 May 2019 at Wolfson College, Linton Rd, Oxford OX2 6UD to transact the business set out in the resolutions below.
Resolutions 1 to 11 will be proposed as ordinary resolutions: this means that for each of those ordinary resolutions to be passed, more than half of the votes cast must be in favour.
Resolutions 12 to 14 will be proposed as special resolutions: this means that for each of those resolutions to be passed, at least three-quarters of the votes cast must be in favour.
To receive the Company s Annual Report and financial statements for the year ended 31 December 2018 together with the strategic report, Directors report and the auditors report on those financial statements.
To approve the Directors remuneration report excluding the directors remuneration policy set out on pages 53 and 54 of the Companys annual report and financial statements for the year ended 31 December 2018.
To approve the Directors remuneration policy set out on page 55 of the Companys Annual Report and financial statements for the year ended 31 December 2018.
To re-elect Susan Searle as a Director.
To re-elect Scott Brown as a Director.
To re-elect Carolan Dobson as a Director 7.
To re-elect Steven Harris as a Director.
To re-elect Dame Pamela Louise Makin as a Director.
To re-appoint Grant Thornton UK LLP as auditor of the Company, to hold office from the conclusion of this meeting until the conclusion of the next meeting at which financial statements are laid before the Company.
To authorise the Board to determine the remuneration of the auditor.
THAT, in accordance with Section 551 of the Companies Act 2006 the Act, the Directors be and are hereby generally and unconditionally authorised to exercise all the powers of the Company to allot ordinary shares in the Company up to a maximum aggregate nominal amount of 908,639, representing approximately 10 per cent of the Companys issued ordinary share capital as at the date of this Notice or, if changed, the number representing 10 per cent of the issued share capital of the Company at the date at which this resolution is passed, such authority to expire at the conclusion of the AGM of the Company to be held in 2020, unless previously renewed, varied, revoked or extended by the Company in general meeting, save that the Company may, before such expiry make offers or agreements which would or might require ordinary shares to be allotted after such expiry and the Directors may allot ordinary shares in pursuance of such offers or agreements as if the authority conferred by this resolution had not expired.
90 Woodford Patient Capital Trust plc 12.
THAT subject to the passing of Resolution 12, and in accordance with Sections 570 and 573 of the Act, the Directors be and are hereby generally empowered to allot equity securities as defined in Section 560 1 of the Act for cash pursuant to the authority conferred on the Directors by Resolution 12 and to sell ordinary shares from treasury for cash, as if Section 561 of the Act did not apply to any such allotment or sale, up to an aggregate nominal amount of 908,639 being 10 per cent of the issued ordinary share capital of the Company at the date of this Notice, or, if changed, the number representing 10 per cent of the issued share capital of the Company at the date at which this resolution is passed, such power to expire at the conclusion of the AGM of the Company to be held in 2020 unless previously renewed, varied, revoked or extended by the Company in general meeting save that the Company may, at any time prior to the expiry of such power, make an offer or enter into an agreement which would or might require ordinary shares to be allotted or sold from treasury after the expiry of such power and the Directors may allot or sell ordinary shares from treasury in pursuance of such an offer or agreement as if such power had not expired.
THAT the Company be and is hereby generally and unconditionally authorised for the purpose of Section 701 of the Act to make market purchases within the meaning of Section 693 4 of the Act of ordinary shares of 1p each in the capital of the Company, provided that: a the maximum number of ordinary shares which may be purchased is 136,205,021 or if changed, the number representing 14.99 per cent of the ordinary shares in issue at the date which this resolution is passed : b the minimum price, exclusive of any expenses, which may be paid for each ordinary share is 1p: c t he maximum price, exclusive of any expenses, which may be paid for each ordinary share shall be to the higher of: i an amount equal to 105 per cent of the middle market quotations for an ordinary share as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the date on which the ordinary share is purchased: and ii the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out.
This authority shall expire at the conclusion of the AGM of the Company to be held in 2020 unless previously revoked, varied, renewed or extended by the Company in general meeting save that the Company may, before such expiry, enter into a contract to purchase shares which will or may be executed wholly or partly after the expiry of such authority.
THAT a general meeting, other than an annual general meeting, may be called on not less than 14 clear days notice.
By order of the Board Link Company Matters Limited Company Secretary 4 April 2019 Beaufort House, 51 New North Road, Exeter, EX4 4EP Woodford Patient Capital Trust plc 91 Important notes to the notice of meeting The following notes explain your general rights as a shareholder and your right to attend and vote at this AGM or to appoint someone else to vote on your behalf.
The Company, pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001, specifies that only those shareholders entered on the Companys register of members at close of business on Tuesday, 14 May 2019 or, if the meeting is adjourned, on the Companys register of members 48 hours before the time fixed for the adjourned meeting, shall be entitled to attend or vote at the meeting in respect of the number of ordinary shares registered in their name at that time.
Changes to entries on the Companys register of members after close of business on Tuesday, 14 May 2019 or, if the meeting is adjourned, 48 hours before the time fixed for the adjourned meeting, shall be disregarded in determining the rights of any person to attend or vote at the meeting.
You may wish to arrive by 10.15am so you can register and take your seat in good time.
Light refreshments will be provided at the meeting.
If you have any special needs or require wheelchair access to the venue, please contact the Company Secretary by telephone on 01392 477500 in advance of the meeting.
Mobile phones may not be used in the meeting hall, and cameras and recording equipment are not allowed in the meeting hall.
Members are entitled to appoint a proxy to exercise all or part of their rights to attend and to speak and vote on their behalf at the AGM.
A shareholder may appoint more than one proxy in relation to the AGM provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder.
A proxy need not be a shareholder of the Company.
To appoint more than one proxy, members will need to complete a separate proxy in relation to each appointment.
The shareholders were duly notified that from 2018 onwards the Company would no longer be posting proxy voting cards to shareholders in order to further reduce the environmental impact.
This year, you can therefore appoint a proxy using one of the following methods: v ia the registrars website www.
To vote online, you will need to log on to your Signal Shares account or register if you have not already done so.
To register, you will need your investor code which can be found on your share certificate.
Once registered, you will immediately be able to vote.
b y requesting a hard copy by calling the registrar Link Asset Services on 0871 664 0391 calls cost 12p per minute plus your phone companys access charge.
Calls outside the United Kingdom will be charged at the applicable international rate.
Open between 9.00 a. m. 5.30 p. m. Monday to Friday excluding public holidays in England and Wales.
In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted.
Seniority is determined by the order in which the names of the joint holders appear in the Companys register of members in respect of the joint holding the first named being the most senior.
Any person to whom this Notice is sent who is a person nominated under Section 146 of the Act to enjoy information rights a Nominated Person may, under an agreement between him her and the shareholder by whom he she was nominated, have a right to be appointed or to have someone else appointed as a proxy for the AGM.
If a Nominated Person has no such proxy appointment right or does not wish to exercise it, he she may, under any such agreement, have a right to give instructions to the shareholder as to the exercise of voting rights.
The statement of the rights of shareholders in relation to the appointment of proxies in notes 3, 4 and 8 does not apply to Nominated Persons.
The rights described in these paragraphs can only be exercised by shareholders of the Company.
A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes for or against the resolution.
If no voting indication is given, your proxy will vote or abstain from voting at his or her discretion.
Your proxy will vote or abstain from voting as he or she thinks fit in relation to any other matter which is put before the AGM.
To be valid, any form of proxy or other instrument appointing a proxy must be received by the Companys Registrar, Link Asset Services, The Registry, 34 Beckenham Road, Beckenham, Kent, BR3 4TU.
In the case of shares held through CREST, via the CREST system see note 12 below.
In each case, for proxy appointments to be valid, they must be received by no later than 10.30am on Tuesday, 14 May 2019 being 48 hours prior to the time of the meeting, not including non-working days.
If you return more than one proxy appointment, either by paper or electronic communication, that received last by the Registrar before the latest time for the receipt of proxies will take precedence.
You are advised to read the terms and conditions of use carefully.
92 Woodford Patient Capital Trust plc 10.
The return of a completed form of proxy, other such instrument or any CREST Proxy Instruction as described in note 12 below will not prevent a shareholder attending the AGM and voting in person if he she wishes to do so.
A member present in person or by proxy shall have one vote on a show of hands and on a poll every member present in person or by proxy shall have one vote for every share of which he she is the holder.
The termination of the authority of a person to act as proxy must be notified to the Company in writing.
CREST members who wish to appoint a proxy or proxies through the CREST electronic proxy appointment service may do so for the AGM and any adjournment of the AGM by using the procedures described in the CREST Manual available from www.
CREST Personal Members or other CREST sponsored members, and those CREST members who have appointed a voting service provider s, should refer to their CREST sponsor or voting service provider s, who will be able to take the appropriate action on their behalf.
In order for a proxy appointment or instruction made by means of CREST to be valid, the appropriate CREST message a CREST Proxy Instruction must be properly authenticated in accordance with Euroclear UK & Ireland Limiteds specifications and must contain the information required for such instructions, as described in the CREST Manual.
The message must be transmitted so as to be received by the issuers agent ID RA10 by 10.30am on Tuesday, 14 May 2019 being 48 hours prior to the time of the meeting, not including non-working days.
For this purpose, the time of receipt will be taken to be the time as determined by the timestamp applied to the message by the CREST application host from which the issuers agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST.
After this time, any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means.
CREST members and, where applicable, their CREST sponsors, or voting service providers should note that Euroclear UK & Ireland Limited does not make available special procedures in CREST for any particular message.
Normal system timings and limitations will, therefore, apply in relation to the input of CREST Proxy Instructions.
It is the responsibility of the CREST member concerned to take or, if the CREST member is a CREST personal member, or sponsored member, or has appointed a voting service provider s, to procure that his CREST sponsor or voting service provider s take s such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time.
In this connection, CREST members and, where applicable, their CREST sponsors or voting system providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.
The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35 5 a of the Uncertificated Securities Regulations 2001.
Any corporation that is a member can appoint one or more corporate representatives who may exercise on its behalf all of its powers as a member provided that no more than one corporate representative exercises powers in relation to the same shares.
To be able to attend and vote at the meeting, corporate representatives will be required to produce prior to their entry to the meeting evidence satisfactory to the Company of their appointment.
As at 3 April 2019 being the last practicable business day prior to the publication of this Notice the Companys issued share capital comprised 908,639,238 ordinary shares of 1p each.
Each ordinary share carries the right to one vote at a general meeting of the Company.
Under Section 527 of the Act, shareholders meeting the threshold requirements set out in that section have the right to require the Company to publish on a website a statement setting out any matter relating to: i the audit of the Companys accounts including the auditors report and the conduct of the audit that are to be laid before the AGM: or ii any circumstances connected with an auditor of the Company ceasing to hold office since the previous meeting at which annual accounts and reports were laid in accordance with Section 437 of the Act.
The Company may not require the shareholders requesting any such website publication to pay its expenses in complying with Sections 527 or 528 of the Act.
Where the Company is required to place a statement on a website under Section 527 of the Act, it must forward the statement to the Companys auditor not later than the time when it makes the statement available on the website.
The business which may be dealt with at the AGM includes any statement that the Company has been required under Section 527 of the Act to publish on a website.
Woodford Patient Capital Trust plc 93 Important notes to the notice of meeting CONTINUED 17.
Any shareholder attending the meeting has the right to ask questions.
The Company must cause to be answered any such question relating to the business being dealt with at the meeting but no such answer need be given if a to do so would interfere unduly with the preparation for the meeting or involve the disclosure of confidential information, b the answer has already been given on a website in the form of an answer to a question, or c it is undesirable in the interests of the Company or the good order of the meeting that the question be answered.
The following documents are available for inspection during normal business hours at the registered office of the Company on any business day until the time of the AGM and may also be inspected at the AGM venue from 10.15am on the day of the meeting until the conclusion of the AGM: copies of the Directors letters of appointment: and a copy of the Articles of Association of the Company.
You may not use any electronic address provided in either this Notice or any related documents including the form of proxy to communicate with the Company for any purposes other than those expressly stated.
A copy of this Notice, and other information required by Section 311A of the Act, can be found on the Companys section of Woodford Investment Management Limiteds website at www.
94 Woodford Patient Capital Trust plc Appendix 1 Further details on top unquoted holdings Company Name Benevolent AI Company Position in Top Ten 2 % of NAV at 31 Dec 18 10.60% % of GAV at 31 Dec 18 8.89% Industry Sector Technology Geography UK Date of Initial Investment 30 06 2015 Cost of Investment to 31 Dec 18 69,852,452 Valuation at 31 Dec 18 86,153,869 Basis of Valuation Last Round Ownership % Undiluted 5.80% Ownership % Diluted 5.40% Income Recognised 0 Turnover 7.2 Pre-tax profits 40.9 Latest accounts date 31 12 2017 Company Name Oxford Nanopore Company Position in Top Ten 3 % of NAV at 31 Dec 18 8.99% % of GAV at 31 Dec 18 7.54% Industry Sector Health Care Geography UK Date of Initial Investment 24 07 2015 Cost of Investment to 31 Dec 18 57,602,735 Valuation at 31 Dec 18 73,081,712 Basis of Valuation Last Round Ownership % Undiluted 4.85% Ownership % Diluted 4.45% Income Recognised 0 Turnover 19.8 Pre-tax profits 50.4 Latest accounts date 31 12 2017 Company Name Proton Partners International Company Position in Top Ten 4 % of NAV at 31 Dec 18 7.93% % of GAV at 31 Dec 18 6.66% Industry Sector Health Care Geography UK Date of Initial Investment 08 06 2015 Cost of Investment to 31 Dec 18 34,500,000 Valuation at 31 Dec 18 64,500,000 Basis of Valuation Last Round Ownership % Undiluted 23.6% Ownership % Diluted 22.7% Income Recognised 0 Turnover 1.1 Pre-tax profits 18.6 Latest accounts date 28 02 2018 Woodford Patient Capital Trust plc 95 Appendix 1 CONTINUED Company Name Immunocore Company Position in Top Ten 6 % of NAV at 31 Dec 18 6.09% % of GAV at 31 Dec 18 5.11% Industry Sector Health Care Geography UK Date of Initial Investment 16 07 2015 Cost of Investment to 31 Dec 18 35,325,346 Valuation at 31 Dec 18 49,513,323 Basis of Valuation IHS Fair Value Approach Ownership % Undiluted 7.0% Ownership % Diluted 6.6% Income Recognised 0 Turnover 25 Pre-tax profits 85 Latest accounts date 31 12 2017 Company Name Oxford Sciences Innovation Company Position in Top Ten 7 % of NAV at 31 Dec 18 4.99% % of GAV at 31 Dec 18 4.19% Industry Sector Financials Geography UK Date of Initial Investment 01 05 2015 Cost of Investment to 31 Dec 18 36,000,000 Valuation at 31 Dec 18 40,600,000 Basis of Valuation Last Round Ownership % Undiluted 5.59% Ownership % Diluted n a Income Recognised 0 Turnover 41.1 Pre-tax profits 34.3 Latest accounts date 31 12 2017 Company Name Atom Bank Company Position in Top Ten 8 % of NAV at 31 Dec 18 4.23% % of GAV at 31 Dec 18 3.55% Industry Sector Financials Geography UK Date of Initial Investment 30 11 2015 Cost of Investment to 31 Dec 18 30,800,000 Valuation at 31 Dec 18 34,400,000 Basis of Valuation Market Approach: Price of Recent Investment Price of Upcoming Investment Ownership % Undiluted 7.64% Ownership % Diluted 7.39% Income Recognised 13.738 Turnover 13.738 Pre-tax profits 52.68m Latest accounts date 31 03 2018 96 Woodford Patient Capital Trust plc Company Name Kymab Company Position in Top Ten 10 % of NAV at 31 Dec 18 2.84% % of GAV at 31 Dec 18 2.38% Industry Sector Health Care Geography UK Date of Initial Investment 30 04 2015 Cost of Investment to 31 Dec 18 16,933,334 Valuation at 31 Dec 18 29,400,000 Basis of Valuation Price of Recent Investment PWERM Ownership % Undiluted 7.90% Ownership % Diluted 7.00% Income Recognised 0 Turnover 5.556m Pre-tax profits 42.717m Latest accounts date 30 09 2018 Company Name Mission Therapeutics Company Position in Top Ten 12 % of NAV at 31 Dec 18 2.32% % of GAV at 31 Dec 18 1.95% Industry Sector Health Care Geography UK Date of Initial Investment 04 02 2016 Cost of Investment to 31 Dec 18 12,500,001 Valuation at 31 Dec 18 18,866,462 Basis of Valuation DCF Black-Scholes Model Ownership % Undiluted 15.40% Ownership % Diluted 13.88% Income Recognised 0 Turnover 745,238 Pre-tax profits 19.989m Latest accounts date 31 12 2017 Woodford Patient Capital Trust plc 97 Notes
